Effect of Smell and Taste of Milk on Feeding Parameters in Preterm Neonates: An Updated Meta-Analysis

Sarah Alenezi1, Manal Aldaihani1, Sabah Alqabandi1

  • 1Department of Medicine and Surgery, Kuwait Institute for Medical Specializations, Kuwait City, KWT.

Cureus
|December 23, 2024
PubMed

Insights

Smell and taste interventions significantly shorten the time for premature infants to achieve oral feeding. This study found these sensory interventions beneficial for preterm infants, reducing feeding duration without impacting other clinical measures.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Sensory Science

Background:

  • Smell and taste stimulation is associated with positive feeding outcomes in premature infants.
  • The specific impact of sensory interventions on the transition to oral feeding in preterm infants requires further clarification.

Purpose of the Study:

  • To evaluate the efficacy of smell and taste interventions in improving clinical outcomes for preterm infants.
  • To determine the effect of sensory interventions on the time to achieve oral feeding in neonates.

Main Methods:

  • A systematic review and meta-analysis of 12 randomized controlled trials (RCTs) involving 1,638 preterm infants (gestational age < 34 weeks).
  • Searches were conducted across major databases (PubMed, Scopus, Web of Science, Cochrane).
  • Study quality was assessed using Cochrane's Risk of Bias tool (version 2); outcomes were analyzed using random-effects models.

Main Results:

  • Smell and taste interventions significantly reduced the time to achieve oral feeds by 1.37 days (95% CI [-2.26, -0.48], p < 0.001).
  • No significant differences were observed for secondary outcomes, including time to full enteral feeds, hospital stay duration, or infection rates.
  • Results remained consistent across subgroup analyses based on birth weight, exposure type, and sample size.

Conclusions:

  • Smell and taste interventions are effective in accelerating the transition to oral feeding in preterm infants.
  • While beneficial for feeding time, these interventions did not significantly alter other clinical outcomes compared to standard care.
  • Further large-scale RCTs and long-term follow-up studies are recommended to fully elucidate the benefits.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
975
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
73